openPR Logo
Press release

Global Uveitis Market | Rising Incidence Fuels Demand for Steroids & Biologics | Major Companies - Novartis Inc., AbbVie, Johnson & Johnson Services Inc.

06-27-2025 09:21 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Uveitis Market

Uveitis Market

The Global Uveitis Market size was valued at US$ 456 million in 2022 and is estimated to reach US$ 837 million by 2031, growing at a CAGR of 4.8% during the forecast period (2024-2031).

The Uveitis Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative product offerings, competitive pricing strategies, financial performance metrics, strategic growth plans, and regional market penetration efforts.

Get exclusive insights - Request your sample report now @ https://datamintelligence.com/download-sample/uveitis-market?ca

Uveitis is an inflammatory condition affecting the uvea-the middle layer of the eye-which includes the iris, ciliary body, and choroid. It can cause redness, pain, blurred vision, and sensitivity to light, and may lead to vision loss if left untreated. Uveitis can result from infections, autoimmune disorders, or be idiopathic, with treatment typically involving corticosteroids, immunosuppressive drugs, or antimicrobial therapy depending on the underlying cause. Prompt diagnosis and management are crucial to prevent complications and preserve vision.

Market Players in the Uveitis market

The prominent players in Uveitis market research report are: Novartis Inc., AbbVie, Johnson & Johnson Services Inc., Amgen, Alimera Sciences, Bausch & Lomb Incorporated., Kiora Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., EyePoint Pharmaceuticals, Inc., Clearside Biomedical

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Uveitis Market Key Development

In June 17, 2022, Sandoz, a generic and biosimilar medicines provider, announced about application acceptance for high concentration formulation of its biosimilar Hyrimoz (adalimumab) by the European Medicines Agency (EMA) for regulatory review. The application covers all indications, including rheumatoid arthritis, uveitis, Crohn's disease, ulcerative colitis and plaque psoriasis.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/uveitis-market?ca

Uveitis Market Segments

By Uveitis Type: Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Pan Uveitis

By Medications: Corticosteroids, Anti-Rheumatic Drugs, Cycloplegic-Mydriatic Drugs, Immunomodulatory Therapy, Biological Therapy, Anti-Viral Drugs, Others

By Medication Form: Eye Drops, Pills, Injections, Implants

By End-User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The Uveitis industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Research Methodology

Our analytical framework employs cutting-edge statistical modeling and data mining techniques to identify emerging patterns, forecast market trajectories, and decode complex industry dynamics. We enhance our findings through sophisticated market segmentation analysis and Porter's Five Forces evaluation, providing a 360-degree view of the competitive landscape. This multi-layered methodology ensures our delivered insights are not only data-driven and credible but also strategically relevant and immediately actionable for critical business decisions.

Regions Covered:

The global Uveitis Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Looking for Full Report Get it Here: https://www.datamintelligence.com/buy-now-page?report=uveitis-market?ca

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Uveitis Market | Rising Incidence Fuels Demand for Steroids & Biologics | Major Companies - Novartis Inc., AbbVie, Johnson & Johnson Services Inc. here

News-ID: 4084639 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Hydropower Market: Company Profiles, Segment Size, and Forecast Through 2024-2031 | Hydro-Quebec, Duke Energy Corporation, Centrais Elétricas Brasileiras S.A., PJSC RusHydro, Ontario Power Generation Inc., Statkraft AS
Hydropower Market: Company Profiles, Segment Size, and Forecast Through 2024-203 …
Hydropower Market reached US$ 244.1 billion in 2022 and is expected to reach US$ 348.2 billion by 2030, growing with a CAGR of 4.8% during the forecast period 2024-2031. The Hydropower Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition.
Medical Aesthetic Device Market Size and Growth Analysis: Rapid Expansion Anticipated- Lumenis Inc., Sciton Inc., and Syneron Medical Ltd, DEKA Laser Technologies, Sigmacon Medical.
Medical Aesthetic Device Market Size and Growth Analysis: Rapid Expansion Antici …
Medical Aesthetic Device Market is expected to grow at a CAGR of 10.5% during the forecast period (2024-2031). The Medical Aesthetic Device Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm
Fetal Monitors Market Detailed Industry Analysis 2024-2031 and Becton, Dickinson and Company, Fujifilm Holdings Corporation, Medtronic PLC, Draegerwerk AG
Fetal Monitors Market Detailed Industry Analysis 2024-2031 and Becton, Dickinson …
Fetal Monitors Market is expected to grow at a CAGR of 7.2% during the forecast period (2024-2031). The Fetal Monitors Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth
Global Medical Oxygen Market Outlook To 2031 | Key Players, Innovations & Regulatory Updates - DataM Intelligence Report
Global Medical Oxygen Market Outlook To 2031 | Key Players, Innovations & Regula …
Medical Oxygen Market is expected to grow at a CAGR of 7.47% during the forecast period 2024-2031 The Medical Oxygen Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At DataM Intelligence, we simplify complex market dynamics into actionable strategies-empowering businesses to remain competitive, scale

All 5 Releases


More Releases for Uveitis

Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures. Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html As per Cochrane,
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &
Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach …
Uveitis Treatment Market Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Uveitis is swelling of the middle layer of the eye,
Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Anterior Uveitis Market: An Industry Case Study
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, …
Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and